Cornerstone National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.4K Hold
1,000
0.02% 120
2026
Q1
$61.7K Hold
1,000
0.02% 108
2025
Q4
$53.9K Hold
1,000
0.02% 99
2025
Q3
$45.1K Hold
1,000
0.02% 102
2025
Q2
$46.3K Hold
1,000
0.02% 98
2025
Q1
$61K Hold
1,000
0.03% 84
2024
Q4
$56.6K Hold
1,000
0.03% 84
2024
Q3
$51.7K Buy
+1,000
New +$46.9K 0.02% 88
2020
Q1
Sell
-8,163
Closed -$524K 58
2019
Q4
$524K Buy
+8,163
New +$467K 0.47% 47

Other funds holding BMY

Cornerstone National Bank & Trust's BMY Position: Q2 2026 in Review

Cornerstone National Bank & Trust held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,000 shares worth $56.4K. The position accounts for 0.02% of the portfolio, ranked #120.

Cornerstone National Bank & Trust first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $524K in Q4 2019. 1,157 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Cornerstone National Bank & Trust held 1,000 shares of Bristol-Myers Squibb worth $56.4K as of Q2 2026.
  • Cornerstone National Bank & Trust left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Cornerstone National Bank & Trust's portfolio in Q2 2026, its #120 holding.
  • Cornerstone National Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
  • Cornerstone National Bank & Trust's Bristol-Myers Squibb position peaked at $524K in Q4 2019.
  • 1,157 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cornerstone National Bank & Trust's 13F filing for Q2 2026, filed 21 Jul 2026.